Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2015 1
2016 3
2017 3
2018 3
2019 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20TJ, 5BAuthor
Page 1
Sequencing cell-type-specific transcriptomes with SLAM-ITseq.
Matsushima W, Herzog VA, Neumann T, Gapp K, Zuber J, Ameres SL, Miska EA. Matsushima W, et al. Nat Protoc. 2019 Aug;14(8):2261-2278. doi: 10.1038/s41596-019-0179-x. Epub 2019 Jun 26. Nat Protoc. 2019. PMID: 31243395 Free PMC article.
Coronary Revascularization in Patients with CKD Stage 5D: Pragmatic Considerations.
Shroff GR, Herzog CA. Shroff GR, et al. J Am Soc Nephrol. 2016 Dec;27(12):3521-3529. doi: 10.1681/ASN.2016030345. Epub 2016 Aug 4. J Am Soc Nephrol. 2016. PMID: 27493258 Free PMC article. Review.
Coronary revascularization decisions for patients with CKD stage 5D present a dilemma for clinicians because of high baseline risks of mortality and future cardiovascular events. ...
Coronary revascularization decisions for patients with CKD stage 5D present a dilemma for clinicians because of high baseline risks o …
Cancer Patients? Willingness to Routinely Complete the EQ-5D Instrument at Clinic Visits.
Naik H, Qiu X, Brown MC, Mahler M, Hon H, Tiessen K, Thai H, Ho V, Gonos C, Charow R, Pat V, Irwin M, Herzog L, Ho A, Xu W, Howell D, Seung SJ, Liu G, Mittmann N. Naik H, et al. J Popul Ther Clin Pharmacol. 2016 Sep 13;23(3):e196-e204. doi: 10.22374/1710-6222.23.1.1. J Popul Ther Clin Pharmacol. 2016. PMID: 27783475
METHODS: 618 adult cancer survivors across multiple cancer disease sites at the Princess Margaret Cancer Centre completed an acceptability survey after completing the EQ-5D instrument. RESULTS: The mean (SD) EQ-5D score was 0.81 (0.15). Among those surveyed, 88% rep …
METHODS: 618 adult cancer survivors across multiple cancer disease sites at the Princess Margaret Cancer Centre completed an acceptability s …
Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with somatoform disorders.
Brettschneider C, König HH, Herzog W, Kaufmann C, Schaefert R, Konnopka A. Brettschneider C, et al. Health Qual Life Outcomes. 2013 Jan 10;11:3. doi: 10.1186/1477-7525-11-3. Health Qual Life Outcomes. 2013. PMID: 23305192 Free PMC article. Clinical Trial.
The EQ-5D showed discriminative ability in patients with different symptom severities. For nearly all reference instruments there were significant differences in mean scores between respondents with and without problems in the various EQ-5D items and strong correlat …
The EQ-5D showed discriminative ability in patients with different symptom severities. For nearly all reference instruments there wer …
The Symptom Monitoring with Feedback Trial (SWIFT): protocol for a registry-based cluster randomised controlled trial in haemodialysis.
Greenham L, Bennett PN, Dansie K, Viecelli AK, Jesudason S, Mister R, Smyth B, Westall P, Herzog S, Brown C, Handke W, Palmer SC, Caskey FJ, Couchoud C, Simes J, McDonald SP, Morton RL. Greenham L, et al. Trials. 2022 May 19;23(1):419. doi: 10.1186/s13063-022-06355-0. Trials. 2022. PMID: 35590395 Free PMC article.
The primary outcome is change in health-related QOL, as measured by EuroQol 5-Dimension, 5-Level (EQ-5D-5L) instrument. Secondary outcomes include overall survival, symptom severity (including haemodialysis-associated fatigue), healthcare utilisation and cost-effectiveness …
The primary outcome is change in health-related QOL, as measured by EuroQol 5-Dimension, 5-Level (EQ-5D-5L) instrument. Secondary out …
Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.
Bansal VK, Herzog CA, Sarnak MJ, Choi MJ, Mehta R, Jaar BG, Rocco MV, Kramer H. Bansal VK, et al. Am J Kidney Dis. 2017 Dec;70(6):859-868. doi: 10.1053/j.ajkd.2017.08.003. Epub 2017 Sep 21. Am J Kidney Dis. 2017. PMID: 28941763
Stroke risk may be more than 3-fold higher among patients with chronic kidney disease stage 5D (CKD-5D) compared to the general population, with the highest stroke rates noted among those 85 years and older. ...However, use of oral anticoagulants for stroke preventi …
Stroke risk may be more than 3-fold higher among patients with chronic kidney disease stage 5D (CKD-5D) compared to the genera …
Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy.
Friedlander M, Rau J, Lee CK, Meier W, Lesoin A, Kim JW, Poveda A, Buck M, Scambia G, Shimada M, Hilpert F, King MT, Debruyne P, Bologna A, Malander S, Monk BJ, Petru E, Calvert P, Herzog TJ, Barrett C, du Bois A. Friedlander M, et al. Ann Oncol. 2018 Mar 1;29(3):737-743. doi: 10.1093/annonc/mdx796. Ann Oncol. 2018. PMID: 29267856 Free article. Clinical Trial.
PATIENTS AND METHODS: HRQoL was measured with EORTC-QLQ-C30, QLQ-OV28 and EQ-5D-3L. Pre-specified end points included mean differences in HRQoL between treatment arms. ...RESULTS: There were statistically significant differences between PZ and P in QLQ-C30 global health st …
PATIENTS AND METHODS: HRQoL was measured with EORTC-QLQ-C30, QLQ-OV28 and EQ-5D-3L. Pre-specified end points included mean difference …
Systematic Review of the Costs and Benefits of Prescribed Cannabis-Based Medicines for the Management of Chronic Illness: Lessons from Multiple Sclerosis.
Herzog S, Shanahan M, Grimison P, Tran A, Wong N, Lintzeris N, Simes J, Stockler M, Morton RL. Herzog S, et al. Pharmacoeconomics. 2018 Jan;36(1):67-78. doi: 10.1007/s40273-017-0565-6. Pharmacoeconomics. 2018. PMID: 28866778
Nabiximols for the management of MS spasticity was not associated with statistically significant improvements in EQ-5D scores compared with standard care. Study quality was moderate overall, with limited inclusion of both relevant societal costs and discussions of potentia …
Nabiximols for the management of MS spasticity was not associated with statistically significant improvements in EQ-5D scores compare …
14 results